Conducting Economic Evaluations Alongside Randomised Trials: Current Methodological Issues and Novel Approaches

Keyphrases

• Economic Evaluation 100%
• Trial-based Economic Evaluation 100%
• Methodological Issues 100%
• Randomized Trial 100%
• Randomized Controlled Trial 50%
• Patient-level Data 50%
• Methodological Challenges 50%
• Health Outcome Measures 50%
• Minimal Clinically Important Difference 50%
• Missing Data 50%
• Resource Cost 50%
• Unbiased Estimate 50%
• Economic Data 50%
• Resource Use 50%
• Health Technology Assessment 50%
• Multinational Trial 50%
• Clinical Outcomes 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Randomized Controlled Trial 100%

Psychology

• Technology Assessment 100%